Improving homocysteine levels through balneotherapy: Effects of sulphur baths

Clinica Chimica Acta

Volumn 343, Issue 1-2, 2004, Pages 105-111

  Leibetseder, Valentin ^a   Strauss Blasche, Gerhard ^a   Holzer, Franz ^b   Marktl, Wolfgang ^a   Ekmekcioglu, Cem ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Kurzentrum ^*  (Austria)

Author keywords

8 hydroxy 2 deoxyguanosine; 8 OHdG; Antioxidative status; Homocysteine; S adenosyl L homocysteine; SAH; Sulphur; Sulphur baths; tHcy; Total plasma homocysteine

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; HOMOCYSTEINE; SULFUR;

ADULT; ARTICLE; BALNEOTHERAPY; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEASUREMENT; OSTEOARTHRITIS; OXIDATIVE STRESS; PRIORITY JOURNAL; SPA TREATMENT; STATISTICAL SIGNIFICANCE; URINALYSIS;

ANTIOXIDANTS; BATHS; CREATINE; DEOXYGUANOSINE; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; SULFUR;

EID: 2042536703     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.12.024     Document Type: Article

References (41)

1. McCully K.S. Vascular pathology of homocysteinemia. Am. J. Pathol. 56:1969;111-128
2. Sutton-Tyrrell K., Bostom A., Selhub J., Zeigler-Johnson C. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation. 96(6):1997;1745-1749
3. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337(4):1997;230-236
4. Bostom A.G., Selhub J. Homocysteine and arteriosclerosis: subclinical and clinical disease associations. Circulation. 99(18):1999;2361-2363
5. Gao W., Jiang N., Meng Z., Tang J. Hyperhomocysteinemia and hyperlipidemia in coronary heart disease. Chin. Med. J. (Engl.). 112(7):1999;586-589
6. Langman L.J., Cole D.E.C. Homocysteine: cholesterol of the 90s? Clin. Chim. Acta. 286(1-2):1999;63-80
7. Whincup P.H., Refsum H., Perry I.J., et al. Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart. 82(4):1999;448-454
8. Al-Obaidi M.K., Stubbs P.J., Collinson P., Conroy R., Graham I., Noble M.I. Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes. J. Am. Coll. Cardiol. 36(4):2000;1217-1222
9. Brattstrom L., Wilcken D.E. Homocysteine and cardiovascular disease: cause or effect? Am. J. Clin. Nutr. 72(2):2000;315-323
10. Senaratne M.P., Griffiths J., Nagendran J. Elevation of plasma homocysteine levels associated with acute myocardial infarction. Clin. Invest. Med. 23(4):2000;220-226
11. Ozkan Y., Ozkan E., Simsek B. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int. J. Cardiol. 82(3):2002;269-277
12. Bayes B., Pastor M.C., Bonal J., et al. Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol. Dial. Transplant. 18(1):2003;106-112
13. Vasan R.S., Beiser A., D'Agostino R.B., et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA. 289(10):2003;1251-1257
14. Vanizor Kural B., Orem A., Cimsit G., Uydu H.A., Yandi Y.E., Alver A. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin. Chim. Acta. 332:2003;23-30
15. Agullo-Ortuno M.T., Albaladejo M.D., Parra S., et al. Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus. Clin. Chim. Acta. 326(1-2):2002;105-112
16. Sun C.-F., Haven T.R., Wu T.-L., Tsao K.-C., Wu J.T. Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker. Clin. Chim. Acta. 321(1-2):2002;55-62
17. Wu L.L., Wu J.T. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin. Chim. Acta. 322(1-2):2002;21-28
18. Kanani P.M., Sinkey C.A., Browning R.L., Allaman M., Knapp H.R., Haynes W.G. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation. 100(11):1999;1161-1168
19. Cavalca V., Cighetti G., Bamonti F., et al. Oxidative stress and homocysteine in coronary artery disease. Clin. Chem. 47(5):2001;887-892
20. Aruoma O.I., Kaur H., Halliwell B. Oxygen free radicals and human diseases. J. R. Soc. Health. 111(5):1991;172-177
21. Leinonen J., Lehtimaki T., Toyokuni S., et al. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 417(1):1997;150-152
22. Ahmad J., Cooke M.S., Hussieni A., et al. Urinary thymine dimers and 8-oxo-2′-deoxyguanosine in psoriasis. FEBS Lett. 460(3):1999;549-553
23. Traber M.G., van der Vliet A., Reznick A.Z., Cross C.E. Tobacco-related diseases. Is there a role for antioxidant micronutrient supplementation? Clin. Chest Med. 21(1):2000;173-187. [x]
24. Shigenaga M.K., Gimeno C.J., Ames B.N. Urinary 8-hydroxy-2′- deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. U. S. A. 86(24):1989;9697-9701
25. Loft S., Fischer-Nielsen A., Jeding I.B., Vistisen K., Poulsen H.E. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J. Toxicol. Environ. Health. 40(2-3):1993;391-404
26. Claiborne A., Yeh J.I., Mallett T.C., et al. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry. 38(47):1999;15407-15416
27. Beinert H. A tribute to sulfur. Eur. J. Biochem. 267(18):2000;5657-5664
28. Sukenik S., Buskila D., Neumann L., Kleiner-Baumgarten A., Zimlichman S., Horowitz J. Sulphur bath and mud pack treatment for rheumatoid arthritis at the Dead Sea area. Ann. Rheum. Dis. 49(2):1990;99-102
29. Smith C.J., Fischer T.H., Heavner D.L., et al. Urinary thromboxane, prostacyclin, cortisol, and 8-hydroxy-2′-deoxyguanosine in nonsmokers exposed and not exposed to environmental tobacco smoke. Toxicol. Sci. 59(2):2001;316-323
30. Slezak P. Das Heilbäderwesen in Österreich und seine gesetzliche Regelung. Mitt. Österr. Sanitätsverwaltung-Sonderdr. 11:1967;3
31. Karagülle M.Z., Tütüncü Z.N., Aslan O., Basak E., Mutlu A. Effects of thermal sulphur bath cure on adjuvant arthritic rats. Phys. Rehab. Kur. Med. 6:1996;53-57
32. Ekmekcioglu C., Strauss-Blasche G., Holzer F., Marktl W. Effect of sulfur baths on antioxidative defense systems, peroxide concentrations and lipid levels in patients with degenerative osteoarthritis. Forsch. Komplement.med. Klass. Nat.heilkd. 9(4):2002;216-220
33. Hildebrandt G., Gutenbrunner C. Balneologie. Hildebrandt G., Gutenbrunner C. Handbuch der Balneologie und Medizinischen Klimatologie. 1998;271-273 Springer, Berlin, Heidelberg
34. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324(17):1991;1149-1155
35. Perry I.J., Refsum H., Morris R.W., Ebrahim S.B., Ueland P.M., Shaper A.G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346(8987):1995;1395-1398
36. Omenn G.S., Beresford S.A., Motulsky A.G. Preventing coronary heart disease: B vitamins and homocysteine. Circulation. 97(5):1998;421-424
37. Eikelboom J.W., Lonn E., Genest J. Jr., Hankey G., Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 131(5):1999;363-375
38. Mitsuhashi H., Nojima Y., Tanaka T., et al. Sulfite is released by human neutrophils in response to stimulation with lipopolysaccharide. J. Leukoc. Biol. 64(5):1998;595-599
39. Petrides P.E. Schwefel. Petrides P.E., Löffler G. Biochemie und Pathobiochemie. 1998;704-705 Springer Verlag, Berlin, Heidelberg
40. Mitsuhashi H., Ikeuchi H., Nojima Y. Is sulfite an antiatherogenic compound in wine? Clin. Chem. 47(10):2001;1872-1873
41. Scheidleder B., Holzer F., Marktl W. Effect of sulfur administration on lipid levels, antioxidant status and peroxide concentration in health resort patients. Forsch. Komplement.med. Klass. Nat.heilkd. 7(2):2000;75-78